Intuitive Surgical (ISRG) Research Coverage Started at UBS Group

UBS Group initiated coverage on shares of Intuitive Surgical (NASDAQ:ISRG) in a research report released on Tuesday morning, 247wallst.com reports. The firm issued a neutral rating and a $540.00 price objective on the medical equipment provider’s stock.

ISRG has been the topic of a number of other research reports. Zacks Investment Research cut shares of Intuitive Surgical from a buy rating to a hold rating in a report on Wednesday, November 21st. Piper Jaffray Companies upgraded shares of Intuitive Surgical from a neutral rating to an overweight rating and set a $600.00 price objective on the stock in a report on Tuesday, October 9th. BidaskClub upgraded shares of Intuitive Surgical from a buy rating to a strong-buy rating in a report on Thursday, August 16th. Canaccord Genuity upgraded shares of Intuitive Surgical from a hold rating to a buy rating and increased their price target for the company from $550.00 to $610.00 in a report on Friday, October 19th. They noted that the move was a valuation call. Finally, Wells Fargo & Co increased their price target on shares of Intuitive Surgical from $575.00 to $635.00 and gave the company an outperform rating in a report on Wednesday, September 12th. One analyst has rated the stock with a sell rating, six have given a hold rating and sixteen have issued a buy rating to the company’s stock. The stock has a consensus rating of Buy and an average price target of $552.41.

Shares of ISRG opened at $530.87 on Tuesday. The stock has a market capitalization of $59.49 billion, a price-to-earnings ratio of 73.83, a price-to-earnings-growth ratio of 3.77 and a beta of 1.02. Intuitive Surgical has a fifty-two week low of $359.75 and a fifty-two week high of $581.12.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, October 18th. The medical equipment provider reported $2.83 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.66 by $0.17. The business had revenue of $920.90 million for the quarter, compared to analysts’ expectations of $916.22 million. Intuitive Surgical had a net margin of 22.31% and a return on equity of 18.79%. The business’s revenue was up 14.0% compared to the same quarter last year. During the same quarter in the prior year, the company earned $2.77 earnings per share. As a group, equities analysts expect that Intuitive Surgical will post 9.52 EPS for the current year.

In other Intuitive Surgical news, COO Salvatore Brogna sold 2,652 shares of the stock in a transaction that occurred on Tuesday, September 4th. The shares were sold at an average price of $557.39, for a total value of $1,478,198.28. Following the transaction, the chief operating officer now directly owns 2,049 shares in the company, valued at $1,142,092.11. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Lonnie M. Smith sold 225 shares of the stock in a transaction that occurred on Wednesday, November 7th. The stock was sold at an average price of $540.04, for a total transaction of $121,509.00. Following the completion of the transaction, the director now owns 379,175 shares in the company, valued at $204,769,667. The disclosure for this sale can be found here. Insiders sold 46,811 shares of company stock worth $23,867,297 over the last quarter. Insiders own 2.20% of the company’s stock.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. CENTRAL TRUST Co raised its position in Intuitive Surgical by 26.4% in the third quarter. CENTRAL TRUST Co now owns 460 shares of the medical equipment provider’s stock worth $264,000 after acquiring an additional 96 shares during the period. Rafferty Asset Management LLC raised its position in shares of Intuitive Surgical by 2.8% during the 3rd quarter. Rafferty Asset Management LLC now owns 3,571 shares of the medical equipment provider’s stock valued at $2,050,000 after purchasing an additional 96 shares during the period. Wedbush Securities Inc. raised its position in shares of Intuitive Surgical by 1.4% during the 2nd quarter. Wedbush Securities Inc. now owns 7,086 shares of the medical equipment provider’s stock valued at $3,391,000 after purchasing an additional 98 shares during the period. Securian Asset Management Inc raised its position in shares of Intuitive Surgical by 0.9% during the 2nd quarter. Securian Asset Management Inc now owns 11,795 shares of the medical equipment provider’s stock valued at $5,644,000 after purchasing an additional 100 shares during the period. Finally, Utah Retirement Systems raised its position in shares of Intuitive Surgical by 0.5% during the 3rd quarter. Utah Retirement Systems now owns 20,881 shares of the medical equipment provider’s stock valued at $11,986,000 after purchasing an additional 100 shares during the period. Institutional investors and hedge funds own 83.68% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. The company's da Vinci surgical System translates a surgeon's natural hand movements, which are performed on instrument controls at a console into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

Featured Article: Systematic Risk and Investors

Analyst Recommendations for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit